BN-2629 Chemical Properties

Boiling point:

805.5±65.0 °C(Predicted)

Density 

1.36±0.1 g/cm3(Predicted)

storage temp. 

Sealed in dry,Room Temperature

solubility 

DMSO: ≥ 100 mg/mL (179.66 mM)

pka

3.88±0.20(Predicted)

form 

Solid

color 

Off-white to yellow

Safety Information

WGK Germany 

WGK 3

Storage Class

11 - Combustible Solids

BN-2629 Usage And Synthesis

Uses

SJG-136 is a DNA cross-linking agent, with an XL50 of 45 nM for pBR322 DNA. SJG-136 has potent antitumor activity.

Biological Activity

Highly potent DNA cross-linking agent th at binds in the minor groove of DNA.

SJG-136 is a highly potent DNA cross-linking agent th at binds in the minor groove of DNA. SJG-136 exhibits potent anticancer activity in numerous cancer cell lines and in vivo. It exhibits significant inhibitory effect against Src activity.

Synthesis

The general procedure for the synthesis of (11aS,11a'S)-8,8'-(propane-1,3-diylbis(oxy))bis(7-methoxy-2-methylene-2,3-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5(11aH)-one) from the compound (CAS:1221969-15-8) was carried out as follows: the solid bis -SEM-dilactam 8 (100 mg, 0.12 mmol) was dissolved in a solvent mixture of ethanol (3 mL) and THF (3 mL). Lithium borohydride (22 mg, 2.3 mmol) was added all at once and the reaction mixture was stirred for 1 h under nitrogen protection. The completion of the reaction was monitored by LC/MS. The reaction mixture was partitioned between water (35 mL) and chloroform (50 mL). The organic phase was washed sequentially with water (35 mL), brine (35 mL), dried over magnesium sulfate and concentrated by rotary evaporation under reduced pressure. The residue was redissolved in a solvent mixture of chloroform (2 mL), ethanol (2 mL) and water (2.5 mL). Silica gel (4 g) was added and the mixture was stirred for 48 hours. The reaction mixture was filtered through a sintered funnel and washed with a solvent mixture of chloroform/methanol (90:10 v/v). The filtrate was extracted with chloroform, washed with brine, dried over magnesium sulfate and concentrated by rotary evaporation under reduced pressure. The residue was purified by fast chromatography (gradient elution: 100% CHCl3 to 97:3 v/v CHCl3/MeOH). The pure grades were collected and the solvent was removed by rotary evaporation under reduced pressure to give the target product SJG-136 as a mixture of imine and methanolamine methyl ether (46 mg, 70% yield). Analytical data: LC/MS 2.50 min (ES-) m/z (relative intensity) 555.06 ([M-H]-, 100); the analytical description is in agreement with the results previously published by Gregson et al. (J. Med. Chem. 2001, 44, 1161-1174). However, the observed [α]20D value was higher than the value reported in the literature: [α]20D = +766° (c = 0.37, HPLC CHCl3) (literature value [α]20D = +358° (c = 0.07, CHCl3)). This discrepancy is within expectations, as spin measurements are extremely sensitive to chloroform purity and the ratio of imine/carbamide adducts.

in vivo

IC 50

Pyrrolobenzodiazepines

References

[1] Gregson SJ, et al. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J Med Chem. 2001 Mar 1;44(5):737-48. DOI:10.1021/jm001064n
[2] Mellinas-Gomez M, et al. Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours. BMC Vet Res. 2015 Aug 19;11:215. DOI:10.1186/s12917-015-0534-2